BENGALURU: A91 Partners has finalised its third fund at $665 million, joining other India-focused venture firms that recently secured funding capital amid growing international attention.
Founded in 2018 by four former executives of Sequoia Capital India (now Peak XV Partners), A91 focuses its investments across various sectors, including consumer, healthcare, financial services, and industrials. The organisation provides growth-stage funding between $10 million and $50 million. Their portfolio includes investments in companies such as Digit Insurance, Atomberg, and Push Health.
The firm announced the fund closure on LinkedIn, emphasising their dedication to supporting Indian entrepreneurs for extended periods. “We started A91… with the belief that patient capital will play an important role in accelerating value creation in Indian businesses,” the post read.
This announcement follows other significant fundraising activities in India’s venture space. Accel secured $650 million for its India and Southeast Asia-focused Fund VIII in Jan 2025, whilst Stellaris Venture Partners concluded its third fund at $300 million last year, maintaining its focus on early-stage investments in SaaS, consumer internet, and fintech.
Despite reduced venture funding for Indian startups throughout 2023 and early 2024, institutional VC funds continue to attract substantial investment. Global limited partners maintain their confidence in India’s long-term potential, particularly in areas driven by domestic consumption, digitalisation, and infrastructure development.